Evidence map›Paper›PMID 27849638›Full record

ArticleAlzheimer disease and associated disorders

Role of APOE ε4 Allele and Incident Stroke on Cognitive Decline and Mortality.

Kumar B Rajan, Neelum T Aggarwal, Julie A Schneider, Robert S Wilson, Susan A Everson-Rose, Denis A Evans

Open access · greenAbstract read
In one paragraph

Article in Alzheimer disease and associated disorders. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kumar B RajanDepartments of *Internal Medicine, Rush Institute for Healthy Aging ‡Neurological Sciences §Behavioral Sciences †Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago IL ∥Department of Medicine, University of Minnesota, Minneapolis, MN.
Neelum T Aggarwal
Julie A Schneider
Robert S Wilson
Susan A Everson-Rose
Denis A Evans
Institute of Behavioral Sciences · JPInstitute of Neurological Sciences · ITRush University Medical Center · USUniversity of Minnesota · US

Funding

Genetic Epidemiology of Cognitive Decline in an Aging Population SampleR01AG030146 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 2007 to 2018
$6.2M
The Center for Health Disparities Research, Engagement, and Training (CeHDRET)P60MD003422 · NIMHD · UNIVERSITY OF MINNESOTA · PI AHLUWALIA, JASJIT SINGH · 2009 to 2013
$6.1M
EPIDEMIOLOGIC STUDY OF PERSONS WITH ALZHEIMERS DISEASER01AG009966 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 1991 to 2009
$5.4M
Nonlinear Models of Cognition Preceding AD in a Biracial Population SampleR01AG051635 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2016 to 2020
$1.5M
NIA NIH HHS R01 AG009966NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG051635NIMHD NIH HHS P60 MD003422
6 · The paper itself

Abstract

backgroundThe apolipoprotein E (APOE) ε4 allele and stroke increase the risk of cognitive decline. However, the association of the APOE ε4 allele before and after stroke is not well understood.

methodsUsing a prospective sample of 3444 (66% African Americans, 61% females, mean age=71.9 y) participants, we examined cognitive decline relative to stroke among those with and without the APOE ε4 allele.

resultsIn our sample, 505 (15%) had incident stroke. Among participants without stroke, the ε4 allele was associated with increased cognitive decline compared to noncarriers (0.080 vs. 0.036 units/year; P<0.0001). Among participants without the ε4 allele, cognitive decline increased significantly after stroke compared to before stroke (0.115 vs. 0.039 units/year; P<0.0001). Interestingly, cognitive decline before and after stroke was not significantly different among those with the ε4 allele (0.091 vs. 0.102 units/year; P=0.32). Poor cognitive function was associated with higher risk of stroke (hazard ratio=1.41, 95% confidence interval, 1.25-1.58), but the APOE ε4 allele was not (P=0.66). The APOE ε4 allele, cognitive function, and incident stroke were associated with mortality.

conclusionsThe association of stroke with cognitive decline appears to differ by the presence of the APOE ε4 allele, but no such interaction was observed for mortality.

Indexed as

AgedAllelesApolipoprotein E4Black or African AmericanCognitive DysfunctionFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMortalityProspective StudiesRisk FactorsStrokeSurveys and QuestionnairesWhite PeopleApolipoprotein E4

Identifiers

PMID27849638
PMCPMC5117953
OpenAlexW2553863697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.